PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1429

Just add to make my point abundantly clear to the ultra sceptics here - it's just a very smart move for PAA to use a first phase MND trial as a pre-trial for the phase two human cancer and covid trials, just in case the tablet, which has been fine turned for dogs, needs a little more fine tuning for humans. After all, a phase one trial does not have to use the medication in the exact form it will be put the health authorities for commercial use, but the final phase 2 test must be the form it will go into the crucial phase 3 trial. Undercanstumble? Cheers